Effects of nitric oxide synthase inhibition on microvascular reactivity in septic mice

Shock

Volumn 12, Issue 4, 1999, Pages 262-267

  Hollenberg, Steven M ^a   Easington, Cordus R ^a   Osman, Jailan ^a   Broussard, Marque ^a   Parrillo, Joseph E ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG DERIVATIVE; ENZYME INHIBITOR; INDUCIBLE NITRIC OXIDE SYNTHASE; N(G) METHYLARGININE; NITRIC OXIDE SYNTHASE; NORADRENALIN; NOS2 PROTEIN, MOUSE; S METHYLISOTHIOPSEUDOURONIUM; S-METHYLISOTHIOPSEUDOURONIUM; THIOUREA DERIVATIVE;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; DRUG ANTAGONISM; DRUG EFFECT; DRUG SCREENING; MALE; MICROCIRCULATION; MICROSCOPY; MOUSE; SEPSIS;

ANIMALS; DRUG EVALUATION, PRECLINICAL; ENZYME INHIBITORS; ISOTHIURONIUM; MALE; MICE; MICE, INBRED BALB C; MICROCIRCULATION; MICROSCOPY, VIDEO; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; NOREPINEPHRINE; OMEGA-N-METHYLARGININE; SEPSIS;

EID: 0033210795     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024382-199910000-00003     Document Type: Article

References (40)

1. Fronek K, Zweifach BW: Microvascular pressure distribution in skeletal muscle and the effect of vasodilation. Am J Physiol 228:791-796, 1975.
2. Nathan C: Nitric oxide as a secretory product of mammalian cells. FASEB J 6:3051-3064, 1992.
3. Forstermann U, Schmidt HHHW, Pollock JS: Isoforms of nitric oxide synthase: characterization and purification from different cell types. Biochem Pharmacol 42:1849-1856, 1991.
4. Grisham MB, Jourd'Heuil D, Wink DA: Nitric oxide. I. Physiological chemistry of nitric oxide and its metabolites: implications in inflammation. Am J Physiol 276:G315-321, 1999.
5. Rees DD: Role of nitric oxide in the vascular dysfunction of septic shock. Biochemical Society 23:1025-1029, 1995.
6. Evans T, Carpenter A, Kinderman H, Cohen J: Evidence of increased nitric oxide production in patients with the sepsis syndrome. Circ Shock 41:77-81, 1993.
7. Ochoa JB, Udekwu AO, Billiar TR, Curran RD, Cerra FB, Simmons RL, Peitzman AB: Nitrogen oxide levels inpatients after trauma and during sepsis. Ann Surg 214:621-626, 1991.
8. Gomez-Jimenez J, Salgado A, Mourelle M, Martin MC, Segura RM, Peracaula R, Moncada S: L-arginine: nitric oxide pathway in endotoxemia and human septic shock. Crit Care Med 23:253-258, 1995.
9. Liu SF, Barnes PJ, Evans TW: Time course and cellular localization of lipopolysaccharide-induced inducible nitric oxide synthase messenger RNA expression in the rat in vivo. Crit Care Med 25:512-518, 1997.
10. Vicaut E, Hou X, Payen D, Bousseau A, Tedgui A: Acute effects of tumor necrosis factor on the microcirculation in rat cremaster muscle. J Clin Invest 87:1537-1540, 1991.
11. Baudry N, Vicaut E, Ba ZF: Role of nitric oxide in effects of tumor necrosis factor-α on microcirculation in rat. J Appl Physiol 75:2392-2399, 1993.
12. Hollenberg SM, Cunnion RE, Zimmerberg J: Nitric oxide synthase inhibition reverses arteriolar hyporesponsiveness to catecholamines in septic rats. Am J Physiol 264:H660-H663, 1993.
13. Gray G, Schott C, Julou-Schaeffer G, Fleming I, Parratt JR, Stoclet J-C: The effect of inhibitors of the L-arginine/nitric oxide pathway on endotoxin-induced loss of vascular responsiveness in anaesthetized rats. Br J Pharmacol 103:1218-1244, 1991.
14. Nava E, Palmer RMJ, Moncada S: The role of nitric oxide in endotoxic shock: Effects of NG-monomethyl-L-arginine. J Cardiovasc Pharmacol 20:S132-S134, 1992.
15. Robertson FM, Offner PJ, Ciceri DP, Becker WK, Pruitt BA Jr: Detrimental hemodynamic effects of nitric oxide synthase inhibition in septic shock. Arch Surg 129:149-156, 1994.
16. Lorente JA, Landin L, De Pablo R, Renes E, Liste D: L-arginine pathway in the sepsis syndrome. Crit Care Med 21:1287-1295, 1993.
17. Petros A., Lamb G, Leone A, Moncada S, Bennett D, Vallance P: Effects of a nitric oxide synthase inhibitor in humans with septic shock. Cardiovasc Res 28:34-39, 1995.
18. Grover R, Lopez A, Lorente J, Steingrub J, Bakker J, Willatts S, McLuckie A, Takala J, International 546C88 Septic Shock Study Group: Multicenter, randomized, placebo-controlled, double blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock. Crit Care Med 27:A33, 1999.
19. Cobb JP, Danner RL: Nitric oxide and septic shock. JAMA 275:1192-1196, 1996.
20. Kubes P, Suzuki M, Granger DN: Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA 88:4651-4655, 1991.
21. Thiemermann C: Selective inhibition of the activity of inducible nitric oxide synthase in septic shock. Prog Clin Biol Res 392:383-392, 1995.
22. Hollenberg SM, Piotrowski MJ, Parrillo JE: Nitric oxide synthase inhibition reverses arteriolar hyporesponsiveness to endothelin-1 in septic rats. Am J Physiol 272:R969-974, 1997.
23. Alexander HR, Doherty GM, Block MI, Kragel PJ, Jensen JC, Langstein HN, Walker E, Norton JA: Single-dose tumor necrosis factor protection against endotoxin-induced shock and tissue injury in rats. Infect Immun 59:3889-3894, 1991.
24. Baez S: An open cremaster muscle preparation for the study of blood vessels by in vivo microscopy. Microvasc Res 5:384-394, 1973.
25. Wiedeman MP: Architecture of the terminal vascular bed. In Reeve EB, Guyton AC (eds): Physical Bases of Circulatory Transport: Regulation and Exchange. Philadelphia, PA: WB Saunders, 1976, pp. 307-312.
26. Hollenberg SM, Cunnion RE: Endothelial and vascular smooth muscle function in sepsis. J Crit Care 9:262-280, 1994.
27. Marshall JJ, Kontos HA: Endothelium-derived relaxing factors. A perspective from in vivo data. Hypertension 16:371-386, 1990.
28. Bohlen HG, Gore RW, Hutchins PM: Comparison of microvascular pressures in normal and spontaneously hypertensive rats. Microvasc Res 13: 125-130, 1977.
29. Meyer J, Traber, LD Nelson S, Lentz CW, Nakazawa H, Herndon DN, Noda H, Traber DL: Reversal of hyperdynamic response to continuous endotoxin administration by inhibition of NO synthesis. J Appl Physiol 73:324-328, 1992.
30. Lorente JA, Landin L, Renes E, De Pablo R, Jorge P, Rodena E, Liste D: Role of nitric oxide in the hemodynamic changes of sepsis. Crit Care Med 21:759-767, 1993.
31. Wu CC, Chen SJ, Szabo C, Thiemermann C, Vane JR: Aminoguanidine attenuates the delayed circulatory failure and improves survival in rodent models of endotoxic shock. Br J Pharmacol 114:1666-1672, 1995.
32. Booke M, Hinder F, Traber LD, McGuire R, Traber DL: S-ethylisothiourea, a nonamino acid inhibitor of nitric oxide synthase, reverses septic vasodilation in sheep. Shock 4:274-281, 1995.
33. Rosselet A, Feihl F, Markert M, Gnaegi A, Perret C, Liaudet L: Selective iNOS inhibition is superior to norepinephrine in the treatment of rat endotoxic shock. Am J Respir Crit Care Med 157:162-170, 1998.
34. Booke M, Hinder F, McGuire R, Traber LD, Traber DL: Selective inhibition of inducible nitric oxide synthase: effects on hemodynamics and regional blood flow in healthy and septic sheep. Crit Care Med 27:162-167, 1999.
35. Filep JG, Delalandre A, Beauchamp M: Dual role for nitric oxide in the regulation of plasma volume and albumin escape during endotoxin shock in conscious rats. Circ Res 81:840-847, 1997.
36. Liaudet L, Rosselet A, Schaller MD, Markert M, Perret C, Feihl F: Non-selective versus selective inhibition of inducible nitric oxide synthase in experimental endotoxic shock. J Infect Dis 177:127-132, 1998.
37. Aranow JS, Zhuang J, Wang H, Larkin V, Smith M, Fink MP: A selective inhibitor of inducible nitric oxide synthase prolongs survival in a rat model of bacterial peritonitis: comparison with two nonselective strategies. Shock 5:116-121, 1996.
38. MacMicking JD, Nathan C, Hom G, Chartrain N, Fletcher DS, Trumbauer M, Stevens K, Xie QW, Sokol K, Hutchinson N, Chen H, Mudgett JS: Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell 81:641-650, 1995.
39. Laubach VE, Shesely EG, Smithies O, Sherman PA: Mice lacking inducible nitric oxide synthase are not resistant to lipopolysaccharide-induced death. Proc Natl Acad Sci USA 92:10688-10692, 1995.
40. Wei XQ, Charles IG, Smith A, Ure J, Feng GJ, Huang FP, Xu D, Muller W, Moncada S, Liew FY: Altered immune responses in mice lacking inducible nitric oxide synthase. Nature 375:408-411, 1995.